Metabolism of endocannabinoids

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Endocannabinoids belong to a group of ester, ether and amide derivatives of fatty acids, which are endogenous ligands of receptors CB1, CB2, TRPV1 and GPR55 that are included in the endocannabinoid system of the animal organism. The best known endocannabinoids are: N-arachidonylethanolamide called anandamide (AEA) and 2-arachidonoylglycerol (2-AG). They occur in all organisms, and their highest level is observed in the brain. In this review the mechanisms of synthesis and degradation of both AEA and 2-AG are shown. Endocannabinoids are synthesized from phospholipids (mainly phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol) located in the cell membrane. As a result of arachidonic acid transfer from phosphatidylcholine to phosphatidylethanolamine, N-arachidonoyl phosphatidylethanolamine is formed, which is hydrolyzed to AEA by phospholipase D, C and A2. However, 2-AG is formed during the hydrolysis of phosphatidylinositol catalyzed mainly by DAGL. The primary role of endocannabinoids is the activation of cannabinoid receptors. Both AEA and 2-AG are primarily agonists of the CB1 receptor and to a lower degree CB2 and TRPV1r eceptors, but 2-AG has stronger affinity for these receptors. Through activation of receptors, endocannabinoids affect cellular metabolism and participate in the metabolic processes by receptor-independent pathways. Endocannabinoids which are not bound to the receptors are degraded. The main enzymes responsible for the hydrolysis of AEA and 2-AG are FAAH and MAGL, respectively. Apart from hydrolytic degradation, endocannabinoids may also be oxidized by cyclooxygenase-2, lipoxygenases, and cytochrome P450. It has been shown that the metabolites of both endocannabinoids also have biological significance.

Authors and Affiliations

Michał Biernacki, Elżbieta Skrzydlewska

Keywords

Related Articles

Targeted therapy with monoclonal antibodies: Do we observe progress in the management of female genital tract cancers?

Targeted therapy with monoclonal antibodies (moAbs) has become a valuable supplementation for classic chemo- and radiotherapy. The first part of this review presents in a condensed way the characteristics and mechanism o...

Angiotensin (1-7): A new link in the renin-angiotensin-aldosterone system (RAAS)

The discovery of a new angiotensin-converting enzyme (ACE2) and studies of the biological activity of angiotensin (1-7) indicate the complexity of the functioning of the renin-angiotensin-aldosterone system (RAAS). In th...

Rola zewnątrzkomórkowych pęcherzyków błonowych w interakcji pasożyt-żywiciel

Zewnątrzkomórkowe pęcherzyki błonowe (EVs, extracellular vesicles), początkowo uważane za elementy zniszczonych komórek, okazały się niezwykle istotnym sposobem przekazywania informacji między komórkami, bez ich bezpośre...

Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia

Background: Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable p...

Kardiotoksyczność jako niepożądane działanie w terapii raka piersi

Udoskonalenie metod stosowanych w terapii raka piersi podniosło skuteczność leczenia oraz wydłużyło czas przeżycia pacjentów po zakończeniu terapii. Towarzyszy jednak temu wzrost częstotliwości występowania działań niepo...

Download PDF file
  • EP ID EP220827
  • DOI -
  • Views 162
  • Downloads 0

How To Cite

Michał Biernacki, Elżbieta Skrzydlewska (2016). Metabolism of endocannabinoids. Advances in Hygiene and Experimental Medicine, 70(), 830-843. https://www.europub.co.uk/articles/-A-220827